Combining our mission and vision with expertise in our lab operations and our technical ... The Ambry acquisition by Tempus just occurred a couple of weeks ago. And so typically, these kinds ...

Cathie Wood’s ARK line of ETFs added more 29,845 Tempus AI (TEM) stock after the company announced the acquisition of Deep 6 AI ...

A: Eric Lefkofsky, CEO, explained that acquiring Ambry provides Tempus with a West Coast lab, complementing existing labs in Chicago, Raleigh, and Atlanta. While there are no immediate plans to ...

CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced it has acquired Deep 6 AI ...

Thomas Fuller / SOPA Images / LightRocket via Getty Images Tempus AI's fourth-quarter results missed estimates as its costs increased. The medical technology firm's non-GAAP operating expenses ...

Leading the day's transactions was a substantial purchase of TEMPUS AI INC (NASDAQ ... The most substantial sale was 41839 shares of ROCKET LAB USA INC (NASDAQ:RKLB), split between ARKQ and ...

Tempus AI reports mixed fourth-quarter financial results. JPMorgan analyst Rachel Vatnsdal downgrades Tempus AI from Overweight to Neutral following the company's quarterly results. Our government ...

Tempus AI's Q4 financials were slightly below expectations but aligned with preliminary results, presenting a buying opportunity due to raised 2025 revenue guidance. The company, a leader in ...

Skyrocketing 108% since the start of 2025, Tempus AI (NASDAQ: TEM), a company applying AI solutions to healthcare, has seen its stock perform exceptionally well this year. Investors have found the ...

D printer manufacturer Bambu Lab has launched a new toy system called CyberBrick under its MakerWorld brand, which pairs ...

Tempus AI stock faces mixed signals ahead of Q4 earnings, with short-term bearish pressure but technical support. Analysts see a 13.5% downside for Tempus AI, while technical indicators suggest ...

Tempus AI held its IPO in June 2024 and is applying AI solutions to healthcare. Investors should watch several metrics to assess the company's growth prospects. While Tempus AI could reap big ...